|
Timber Pharmaceuticals Inc (NYSE: TMBR) |
|
Timber Pharmaceuticals Inc
TMBR's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Timber Pharmaceuticals Inc growth rates, revenue grew
in II. Quarter 2023 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -8.1 %
Timber Pharmaceuticals Inc net loss decreased from $-9 millions, to $-4 millions in II. Quarter 2023,
• More on TMBR's Growth
|
|
Timber Pharmaceuticals Inc realized a net loss in trailing twelve months.
Timber Pharmaceuticals Inc realized cash reduction of $ -1.87 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 64.84.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
• More on TMBR's Valuation
|
|
|
|
|
Timber Pharmaceuticals Inc realized net loss in trailing twelve months.
Timber Pharmaceuticals Inc realized cash outflow of $ -1.87per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 64.84.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
• More on TMBR's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com